Search Results
Found 26 results
510(k) Data Aggregation
(115 days)
Fluent Pro Fluid Management System Waste Bag Multipack (5-pack) (FLT-205) Regulation Number: 21 CFR 884.1700
|
| Regulatory Number: | 21 CFR 884.1700
|
| Regulatory Number: | 21 CFR 884.1700
|
| Regulation
Number | 21 CFR 884.1700
| 21 CFR 884.1700
The Fluent Pro Fluid Management System is intended to provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation liquid flowing into and out of the uterus while providing drive, control and suction for hysteroscopic morcellators.
The Fluent Pro Fluid Management System is a hysteroscopic fluid management system and drive console for hysteroscopic morcellators. The Fluent Pro Fluid Management System consists of a console and single-use procedure kit. The single-use procedure kit consists of sterile inflow (In-FloPak) and outflow (Out-FloPak) tube sets, and a non-sterile waste bag. The FloPaks and waste bag connect for use in hysteroscopic procedures. The console includes motors that control fluid inflow and outflow for hysteroscopic insufflation, as well as a pressure sensor monitoring system and graphical user interface. In addition, the console includes a connection for MyoSure Tissue Removal Devices and a pneumatic foot pedal to perform tissue removal procedures. The Fluent Pro Fluid Management System is compatible with currently marketed MyoSure Tissue Removal Devices.
This FDA 510(k) summary describes a medical device, the Fluent Pro Fluid Management System, for which substantial equivalence is claimed against a predicate device. The document focuses on regulatory compliance and device characteristics rather than a clinical study evaluating diagnostic or treatment efficacy.
Therefore, the requested information regarding acceptance criteria, reported device performance, sample sizes for test/training sets, data provenance, expert ground truth, adjudication methods, multi-reader multi-case studies, and standalone algorithm performance cannot be fully extracted or accurately described from the provided text. These types of details are typically found in clinical study reports, which are not included here.
However, based on the provided text, I can infer and extract some information related to performance testing and acceptance criteria as described in the context of device safety and functional equivalence:
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria here are functional and safety performance, demonstrated through various engineering and bench tests, rather than clinical efficacy metrics.
Performance Metric | Acceptance Criteria (Implied/Directly Stated) | Reported Device Performance (Summary) |
---|---|---|
Biocompatibility | Compliance with ISO 10993-1, 5, 10, 11, 23 (cytotoxicity, sensitization, systemic toxicity, irritation) | Patient contacting materials are biocompatible and comply with ISO 10993-1:2018 requirements. |
Sterilization | Compliance with ISO 11135:2014 | Sterilization validation conducted in accordance with ISO 11135:2014. |
Shelf-Life | Compliance with ASTM F1980 (36 months shelf life) | Passed shelf-life testing per ASTM F1980, achieving a 36-month shelf life. |
Electrical Safety & EMC | Compliance with IEC 60601-1 and IEC 60601-1-2 | Underwent electrical safety and EMC testing in accordance with IEC 60601-1 and IEC 60601-1-2. |
Intrauterine Pressure Control & Fluid Deficit Accuracy | Deficit Accuracy: ± 50 mL under normal use (specified for predicate and proposed device) | Passed Intrauterine Pressure Control and Fluid Deficit Bench Testing. (Implied: met ± 50 mL accuracy) |
System Mechanical, Hardware, Electrical | Not explicitly stated but implied to meet design specifications | Passed System Mechanical, Hardware, and Electrical Bench Testing. |
Software | Not explicitly stated but implied to meet design specifications | Passed Software Unit, Integration, and System Testing. |
Disposables (Pull Force, Flow Rate, Duty Cycle) | Not explicitly stated but implied to meet design specifications | Passed Disposables Pull Force, Flow Rate, and Duty Cycle Bench Testing. |
Usability | Compliance with IEC 62366-1:2015 + A1:2020 and FDA Guidance | Passed simulated use testing in accordance with IEC 62366-1 and FDA Guidance. |
2. Sample size used for the test set and the data provenance
The document does not specify exact sample sizes for the various performance tests (e.g., number of units tested for electrical safety, number of sterility tests etc.). The provenance of the "data" is from internal company testing and validation activities as part of the 510(k) submission process. These are all prospective tests conducted on the device.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable in the context of this 510(k) submission. The "ground truth" for these engineering and performance tests is defined by adherence to international standards and design specifications, not expert consensus on medical images or patient outcomes.
4. Adjudication method
Not applicable. Testing involves engineering verification and validation against objective standards and specifications, not subjective expert adjudication.
5. Multi-reader multi-case (MRMC) comparative effectiveness study
No, an MRMC comparative effectiveness study was not done or reported in this 510(k) summary. This type of study is relevant for diagnostic devices where human readers interpret medical data (e.g., images) with and without AI assistance to assess improved accuracy or efficiency. The Fluent Pro Fluid Management System is a hysteroscopic insufflator and morcellator control system; its functions are mechanical and fluidic control, not diagnostic interpretation.
6. Standalone (i.e. algorithm only without human-in-the loop performance) was done
This refers to an AI algorithm's performance without human interaction. This is not applicable to the Fluent Pro Fluid Management System, as it is a physical medical device with software components that control mechanical actions, not an AI-driven image analysis or diagnostic algorithm. Its "performance" is its functional operation in conjunction with a human operator during a hysteroscopic procedure.
7. The type of ground truth used
For the performance testing mentioned, the "ground truth" is defined by:
- International Standards: e.g., ISO 10993 for biocompatibility, ISO 11135 for sterilization, IEC 60601-1/1-2 for electrical safety/EMC, IEC 62366-1 for usability.
- Device Design Specifications: For metrics like Intrauterine Pressure Control, Fluid Deficit Accuracy (± 50 mL), Maximum Inflow Rate, etc. These are objective engineering parameters.
8. The sample size for the training set
Not applicable. The Fluent Pro Fluid Management System is not an AI/ML device that requires a "training set" in the conventional sense for learning and model development. The software within the device undergoes testing (unit, integration, system testing) to ensure it performs according to its predefined logical and control functions, not to train a learning algorithm.
9. How the ground truth for the training set was established
Not applicable, as there is no "training set" for an AI/ML algorithm.
Ask a specific question about this device
(205 days)
|
6
| Regulation Number: | 21 CFR 884.1700
The Monarch® Platform, Urology and its accessories are intended to access and visualize anatomical locations within the urinary tract and interior of adolescents and adults, aged 12 and up, for diagnostic and therapeutic procedures with transurethral access or transurethral access in conjunction with percutaneous access.
The Monarch® Platform, Urology, the Ureteroscope, and endourology accessories are indicated to provide endoscopic visualization and access of organs, cavities and canals in the urinary tract (urethra, bladder, ureter, calyces and renal papillae) with transurethral access or transurethral access in conjunction with percutaneous access routes. It can also be used in conjunction with endoscopic accessories to perform various diagnostic and therapeutic procedures in the urinary tract.
The Monarch® Platform, Urology ("Proposed Device") is a capital equipment platform that enables electro-mechanical articulation and precise control of a flexible ureteroscope and/or a flexible suction catheter for visualization and access to the urinary tract for diagnostic and therapeutic procedures. The ureteroscope and suction catheter move only under continuous and direct physician control, via the Monarch Controller.
The proposed device consists of Monarch® Tower, Monarch® Cart, Monarch® Fluidics Pump, Monarch® Software, Monarch® Controller, Monarch® Ureteroscope and endourology instruments and accessories needed to perform Monarch Urology diagnostic and therapeutic procedures. The device as well as its instruments and accessories are used together during urological diaenostic and therapeutic procedures and are bundled in this 510(k) submission so they can be addressed during one review. The summary descriptions of each component are outlined below.
Monarch® Tower: The Monarch® Tower (Tower) contains the primary procedural display interface for the physician that is provided by a touchscreen monitor for physician viewing and computers running the Monarch software. The monitor has a touchscreen and allows for user input during setup and intra-operative use. The tower has integrated electromagnetic (EM) tracking and video signal processing components. In addition, the tower provides connectivity for the endoscope camera as well as the fluidics pump.
Monarch® Cart: The Monarch® Cart (Cart) contains a touchscreen, three robotic arms and electronic systems required to power and operate the robotic arms. The Cart touchscreens accepts user input and shows instructions for arm deployment and cart functions. The robotic arms possess multiple degrees of freedom. The cart transmits the physician directed movement to the Ureteroscope and other instruments during a procedure.
Monarch® Fluidics Pump: The Monarch® Fluidics Pump (Fluidics Pump) controls the irrigation and suction during a procedure. The Fluidics Pump is connected to the Monarch Tower via an umbilical cable allowing electrical and data communication. The Fluidics Pump provides the physician with the ability to control irrigation and suction levels during a procedure. The Urology Irrigation Cartridge and Suction Set are irrigation and suction tubing provided as sterile accessories to connect the Fluidics Pump to the Ureteroscope and Instruments during ureteroscopy or PCNL procedures.
Monarch® Software: The Monarch® Software provides the user with the ability to safely drive the Monarch® Ureteroscope and Monarch® Mini-PCNL suction catheter around the kidney and within the calyces of interest as well as provides optional navigation guidance to the user to insert the needle to the target during Monarch® PCNL procedure. It receives user input from the Monarch® Controller, computes the appropriate robotic motion to coordinate the movement of the robotic arms and endoscopic devices loaded onto the Cart. It provides a graphical user interface where the endoscopic camera view is shown in real time and displays important system status information.
Monarch® Controller: The Monarch® Controller) is a handheld device that serves as the user interface that allows the physician to control the system during a procedure. An Umbilical cord connects the Controller to the Tower.
Monarch® Ureteroscope: The Monarch® Ureteroscope (Ureteroscope) is comprised of an endoscope that provides vision, illumination, and a working channel to the distal tip of the device. The Ureteroscope can be navigated by the user within the bladder, urinary tract, and kidney. It contains a working channel to accommodate compatible commercially available working channel instruments. The Ureteroscope can be articulated 2-directions (along a single plane) when manually driven or can be articulated 4-directions (along two planes) when mounted to the electromechanical arms under command by the physician using the endoscopic controller. The shaft of the ureteroscope can also be rolled 155° in either direction to reorient the camera and working channel. The Ureteroscope is packaged within the Monarch® Ureteroscopy Kit. The Monarch® Ureteroscopy Kit also includes Ureteroscope Valve, Ureteroscope Driver and Laser Driver (accessories for Ureteroscopy procedure).
Procedural specific instruments and accessories for the proposed device are outlined below, these devices are single-use devices and sterilized via EO.
- Monarch® Mini-PCNL Suction Catheter: The Monarch® Mini-PCNL Suction Catheter ● (Suction Catheter) is part of the Monarch® Mini-PCNL Kit. The Suction Catheter is a flexible device that is inserted into the kidney via antegrade tract under direct visualization from the ureteroscope. It has a center lumen which allows for the suction of stone debris and can articulate in 4 directions. The suction catheter is manipulated by one robotic arm under the control of a physician who is concurrently controlling the Ureteroscope.
- Dilation Set: The Dilation Set is part of the Monarch® Mini-PCNL Kit. The Dilation Set ● includes:
- 8Fr dilator
- 10Fr catheter
- Percutaneous Sheath Dilator ●
- Percutaneous Sheath: The Percutaneous Sheath is part of the Monarch® Mini-PCNL Kit. The Percutaneous Sheath consists of an inner metal sheath with a threaded connection and a metal outer sheath. It is designed to establish percutaneous access and designed to allow simultaneous irrigation and suction of fluid to support removal of kidney stones. The outer sheath has a molded hub with an angled luer connection for irrigation and an insertion depth marking on the distal end.
The provided text describes performance data but does not specify quantifiable acceptance criteria for the Monarch® Platform, Urology device. Instead, it states that the device was tested against internal design specifications and applicable performance standards to demonstrate safety and effectiveness, and that "all intended user needs evaluated met their acceptance criteria." However, what those specific quantitative acceptance criteria were for different aspects (e.g., accuracy, reliability, image quality) and the reported performance against them are not detailed in the provided document.
Therefore, the following information is based on what can be extracted or inferred from the provided sections, recognizing the absence of explicit quantitative acceptance criteria and specific performance metrics for the device itself.
1. Table of Acceptance Criteria and Reported Device Performance
As mentioned above, the document does not provide a table of explicit acceptance criteria with specific quantitative targets and corresponding reported device performance values. The general statements are that all tests "Passed" or "met acceptance criteria."
Therefore, I cannot construct the requested table with specific numerical values for acceptance criteria and reported device performance.
2. Sample Size Used for the Test Set and Data Provenance
The document mentions "live porcine model" for Design Validation and "Acute Animal Safety" studies.
- Sample Size for Test Set: Not explicitly stated as a numerical count for either the Design Validation or Acute Animal Safety studies. The phrasing "live porcine model" and "live animal model" are general.
- Data Provenance: The studies were conducted using "live porcine model" and "live animal model," indicating animal testing (pre-clinical). The location or country of origin is not specified, but it suggests a controlled laboratory setting. The studies are prospective in nature, as they involve active testing and data collection.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
The document mentions "intended users" and "representative users" in the context of Human Factors and Usability evaluation and Design Validation. However, it does not specify the number of experts used to establish ground truth for any test set or their specific qualifications (e.g., "radiologist with 10 years of experience").
4. Adjudication Method for the Test Set
The document does not describe any adjudication method (e.g., 2+1, 3+1) for establishing ground truth for any test set. The term "ground truth" itself is not explicitly used in the context of expert review in the provided text.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs without AI Assistance
The document does not mention or describe a Multi Reader Multi Case (MRMC) comparative effectiveness study. The Monarch® Platform is described as a capital equipment platform with electromechanical articulation and control, and software for navigation, but there is no indication of an AI component designed to assist human readers in interpretation or diagnosis, nor any study comparing human performance with and without AI assistance.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
The document describes the Monarch® Platform as a system that requires "continuous and direct physician control" and where "Device movement is only at the command of the physician." The software provides "optional navigation guidance." This indicates that the device is designed for human-in-the-loop operation, and the description does not support the idea of a standalone (algorithm-only) performance study.
7. The Type of Ground Truth Used
Based on the descriptions:
- Design Validation and Acute Animal Safety: The "ground truth" for these studies would implicitly be established through direct observation, physiological measurements, and potentially post-mortem examination in the animal models, assessing safety and functionality in a simulated use environment. This is a form of direct-measurement or observation-based ground truth specific to animal model performance.
- Other tests (Reprocessing, Sterility, Biocompatibility, Electrical Safety, Software, Verification Testing, Human Factors): These rely on adherence to established standards and internal specifications, where "ground truth" is defined by the objective pass/fail criteria of technical tests rather than expert consensus on diagnostic images or pathology.
8. The Sample Size for the Training Set
The document describes pre-market testing and validation for a medical device (Monarch® Platform, Urology). It does not mention a "training set" in the context of machine learning or AI, as the primary focus seems to be on the electromechanical system and software components rather than a learning algorithm that requires a training set.
9. How the Ground Truth for the Training Set Was Established
As no "training set" for an AI/ML algorithm is mentioned, this question is not applicable based on the provided text.
Ask a specific question about this device
(247 days)
Ohio 44139
Re: K210628 Trade/Device Name: X-FLO Fluid Management System Regulation Number: 21 CFR 884.1700
Insufflator Classification Name: Insufflator, Hysteroscopic Regulatory Class: II Regulation Number: 21 CFR 884.1700
The X-FLO Fluid Management System is intended to:
· Warm and pump fluid, via intravenous (IV) bags or fluid bottles, to provide fluid distention and flushing of the uterus for gynecology procedures. The device can also measure fluid deficit of the surgical procedure.
· Warm and pump fluid, via IV bags or fluid bottles, to provide fluid distention and flushing of the bladder and kidneys, or general distention and flushing, for urological procedures. The device can also measure fluid deficit of the surgical procedure.
· Warm and pump fluid, via IV bags or fluid bottles, to provide fluid distention and flushing of the shoulder, knee, or other small joints for orthopedic procedures. The device can also measure fluid deficit of the surgical procedure.
The X-FLO Fluid Management System ("X-FLO") (P/N 01910), with an optional deficit module (P/N 01601) is intended for fluid distention, fluid warming, and fluid volume/deficit measurements, as well as external suction regulation pertaining to deficit measurements for diagnostic and/or operative endoscopic procedures within gynecology, urology, and orthopedic disciplines.
The X-FLO utilizes a touchscreen user interface and performs fluid pressurization, warming, and volume/deficit monitoring functions. More specifically, the device employs a peristaltic pump to pressurize and deliver fluid to the surgical site for distending and continually flushing the surgical site for visualization purposes, utilizes infrared lamps to optionally warm the fluid to body temperature, and uses fluid bag weight to monitor fluid inflow.
Regarding the optional deficit monitoring function, the device utilizes external suction to return fluid from the surgical site. The X-FLO monitors and adjusts the vacuum level to the operator selected setpoint by opening the suction line to atmosphere if necessary. Once the fluid is returned from the surgical site, the single-use deficit cartridge measures the fluid volume collected, prior to transfer to fluid collection equipment and/or the hospital's waste disposal system.
The X-FLO is controlled via a Graphical User Interface (GUI), wherein the user is guided to select a surgical discipline and a procedure type. Once selected, the user can input the desired setpoint within the established minimum and maximum parameters for that procedure type. As set forth below, the X-FLO can operate in Pressure Control (the default control, or X-Control. Each control view has defaults and adjustment ranges for fluid pressure, flow, temperature, deficit alarm, and external suction regulation.
In addition to adjusting the fluid pressure setpoint via the GUI, the user may optionally utilize a foot pedal included with the X-FLO to temporarily increase the fluid pressure. By pressing the foot pedal, the user initiates an increase in fluid pressure. The increase is user configurable but can never exceed the maximum allowable fluid pressure for the procedure. When the user desires to have the fluid pressure return to the setpoint, the foot pedal is released.
The provided text details the 510(k) submission for the Thermedx X-FLO Fluid Management System, which is a medical device intended for fluid distention, warming, and volume/deficit measurements during various endoscopic procedures.
Here's an analysis of the acceptance criteria and study data based on the provided document:
Acceptance Criteria and Reported Device Performance
The document presents a comparison table between the subject device (X-FLO Fluid Management System) and its predicate device (FluidSmart), which implicitly defines the performance criteria. The relevant criteria mainly relate to fluid warming, fluid delivery (pressure/flow), and deficit monitoring.
Table of Acceptance Criteria and Reported Device Performance:
Feature/Criterion | Acceptance Criteria (from comparison with predicate/stated capability) | Reported Device Performance (X-FLO Subject Device K210628) |
---|---|---|
I. Imaging/AI Specifics | (Not Applicable - This is not an AI/imaging device) | (Not Applicable - This is not an AI/imaging device) |
II. Device Performance | ||
Fluid Warming | ||
Heating Technology | Infrared lamps | Infrared lamps |
Fluid Warming Rate | Increase inlet fluid temp to 40°C. | Capable of increasing inlet fluid temperature from 18 °C ± 1 °C to 40 °C ± 3 °C for flow rates 800 mL/min. |
Maximum Setpoint | 40°C | 40 °C |
Temperature Measurement | Measured at exit from cartridge component of tubing set | Irrigation fluid temperature measured at exit from the cartridge component of the tubing set |
Temperature Displayed | Displayed at GUI | Irrigation fluid temperature displayed at GUI. |
Over-temperature Safety | Disable pumping if fluid temp exceeds set-point + 3°C | The device will disable the lamps if the fluid temperature reaches 41.5 ± 1 °C. The device will disable pumping if the actual fluid temperature reaches 46 ± 1 °C. |
Fluid Delivery | ||
Pumping Mechanism | Peristaltic pump | Peristaltic pump with ability to reverse to relieve pressure |
Pressure Measurement | (Implied accurate measurement) | Dual transducers measuring fluid pressure |
Maximum Flow Rate | 1200 mL/min (stated for predicate) | 1200 mL/min |
Fluid Pressure | 30-300 mmHg (predicate) | 30-350 mmHg |
Max Fluid Vessel Size | (2) 5-Liter (predicate) | (4) 5-Liter (Note: The document states this "does not raise different questions of safety and effectiveness") |
Fluid Weight Accuracy | ± 10% or 250 mL (whichever is greater) (predicate) | ± 5 mL (Note: This is significantly more precise than the predicate's reported accuracy) |
Temporary Pressure Increase | User interface (predicate) | Foot pedal or User interface |
Over-pressure Safety | Audible/visual notifications, suspend fluid flow if outside ±10% or 12mmHg | Audible and visual notifications and disable pumping if the fluid pressure exceeds the setpoint by the greater of 10% or 12 mmHg. Disable pumping prior to irrigation pressure exceeding the maximum set point by more than the higher of 10% or 12 mmHg. |
Deficit Monitoring | ||
Fluid Deficit Monitoring | Yes | Yes |
Monitoring Accuracy Spec | The greater of 250ml or 10% of the volume pumped (predicate) | 1 – 1000 mL: ± 75 mL; 1000 – 2500 mL: ± 5 %; 2500 – 5000 mL: ± 3 %; ≥ 5000 mL: ± 2.2 % (Note: This is a different and more precise specification than the predicate's reported accuracy) |
Measurement Means | Measurement by weight (predicate) | Measurement by flow (Note: This is a different method than the predicate, justified by performance testing) |
Fluid Deficit Display | Displayed on GUI (predicate implied) | Displayed on GUI |
External Suction Regulation | None (predicate) | 0-400 mmHg Suction Setpoint Range (Note: New feature, justified as not raising new questions of safety/effectiveness as it can be evaluated by performance testing) |
Over-deficit Safety (Isotonic) | Audible/visible notification, suspend fluid flow if deficit reached | The device will disable pumping when the default setpoint or maximum deficit volume (2,500 mL) is reached |
Over-deficit Safety (Hypotonic) | (Not applicable for predicate) | The device will disable pumping and provide audible notification when the deficit level reaches the deficit alarm setpoint inputted by the user. The device will disable pumping and provide audible notification when the maximum allowable deficit level of 2,500 mL is reached if the fluids used are a combination of isotonic and hypotonic. The device will disable pumping when the maximum deficit of 1,000 mL is reached. (Note: New feature due to the new deficit measurement method) |
III. Other Performance | ||
Biocompatibility | Compliant with ISO 10993-1, 5, 10, 11 | Conducted per 2020 FDA guidance. Tests include: Cytotoxicity (ISO 10993-5:2009), Sensitization (ISO 10993-10:2010), Irritation (ISO 10993-10:2010), Acute Systemic Toxicity (ISO 10993-11:2017) |
Electrical Safety & EMC | Compliant with IEC 60601-1, 1-2, 1-6 | Complies with IEC 60601-1:2005 + CORR. 1 (2006) + CORR. 2 (2007) + AM1 (2012), IEC 60601-1-2:2014, and IEC 60601-6:2010 + A1:2013. |
Software V&V Testing | Compliant with FDA guidance for "major" level of concern | Conducted as recommended by 2005 FDA guidance document. Software considered "major" level of concern. |
Sterility & Shelf-Life | Sterile, compliant with ISO 11135, ASTM F198/F1929/F88 | Sterilized via Ethylene Oxide per ISO 11135:2014. Shelf life of 6 months. Shelf-life testing per accelerated aging (ASTM F198-16) with visual inspection (ASTM F1929-15) and seal strength (ASTM F88). |
Bench Testing | Specifications met in simulated use for various parameters | Evaluated alarm sound levels, tubing/cartridge leak testing, tubing mechanical strength, fluid sensing, fluid compatibility (sterile water, lactated ringers, mannitol, glycine, saline, sorbitol), irrigation pressure controls (with three hysteroscope models), over-temperature, over-pressure, over-deficit testing, tissue trap capacity, deficit calculation accuracy, empty fluid bag detection, temperature accuracy, and pressure and flowrate accuracy. |
Study Proving Device Meets Acceptance Criteria:
The document describes non-clinical performance testing conducted to support the substantial equivalence determination.
-
Sample Size Used for Test Set and Data Provenance:
- The document implies that testing was performed on representative units of the device and its accessories (tubing sets, deficit cartridge, etc.).
- Sample Size: Not explicitly stated as a number of devices or data points for each bench test. For example, "Fluid compatibility with sterile water, lactated ringers solution, 5 % mannitol solution, 1.5 % glycine solution, 0.9% saline solution, and sorbitol solution" implies multiple tests, but the quantity of tests, runs, or devices tested for each parameter is not specified. Similarly, "Irrigation pressure controls with three different hysteroscope models" specifies the models but not the number of runs or devices.
- Data Provenance: The document does not specify the country of origin of the data. It is a 510(k) submission to the US FDA, so the testing was presumably conducted in a manner acceptable for US regulatory submission. The studies are bench/laboratory studies focused on device performance, not patient data studies, so "retrospective or prospective" is not an applicable distinction in the sense of patient data collection.
-
Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications:
- This is a technical performance study of a medical device, not a study involving human interpretation of clinical data (like AI for imaging). Therefore, the concept of "experts establishing ground truth" in the clinical sense (e.g., radiologists) is not applicable. The "ground truth" for these tests is the physical measurement of device performance against engineering specifications using calibrated equipment and standard test methods.
-
Adjudication Method for the Test Set:
- Not Applicable. As this involves objective bench testing, there is no "adjudication" in the sense of reconciling subjective expert opinions. Device performance measurements are compared directly against pre-defined engineering and regulatory specifications.
-
If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:
- No. This is not an AI/imaging device or a device whose performance is dependent on human reader interpretation. Therefore, an MRMC study is not relevant.
-
If a Standalone (algorithm only without human-in-the-loop performance) was done:
- Not Applicable. While the device has software ("Software controlled"), its performance is measured as an integrated system (hardware and software) in bench testing, not as a standalone algorithm evaluating clinical data. The "stand-alone" performance is implicitly the results of the bench testing.
-
The Type of Ground Truth Used:
- The "ground truth" for the performance studies is the pre-defined engineering specifications and internationally recognized standards (e.g., IEC 60601 series for electrical safety, ISO 10993 for biocompatibility) that the device must meet. Performance metrics (e.g., temperature, pressure, flow rate, deficit volume) are objectively measured using calibrated instruments during bench testing.
-
The Sample Size for the Training Set:
- Not Applicable. This is a hardware medical device with embedded software; it does not involve machine learning or AI models that require "training sets" in the conventional sense of data-driven model training. The software is developed and verified via traditional software engineering principles.
-
How the Ground Truth for the Training Set Was Established:
- Not Applicable. (As explained above, no traditional training set exists for this type of device.) The "ground truth" for software functionality testing (verification and validation) would be the software requirements specifications derived from the device's intended use and design.
Ask a specific question about this device
(62 days)
Baden-Wurttemberg 78532 Germany
Re: K201355
Trade/Device Name: Endomat Select Regulation Number: 21 CFR§ 884.1700
Common Name: Suction Irrigation Pump
Classification Name: Hysteroscopic insufflator (21 CFR Part 884.1700
|
| Regulation: | 884.1700
Endomat Select is intended to:
· provide the infusion of the sterile irrigant solutions into the ureter and upper urinary tract, as well as to suction off the irrigation fluids, bodily fluids, secretions, tissue and gas during diagnostic and operative endoscopic urological procedures
· provide the infusion of the sterile irrigant solutions into the uterus, as well as to suction off the irrigation fluids, bodily fluids, secretions, tissue and gas during diagnostic and operative endoscopic hysteroscopic procedures
· provide the infusion of the sterile irrigant solutions into organs and operating diagnostic and operative procedures in laparoscopic and open general surgery
· provide sustained liquid irrigation of joint or intra-articular spaces during all phases of arthroscopic surgery
· provide the infusion of the sterile irrigant solutions in order to enable the Lens Cleaning during endoscopically assisted Functional Endoscopic Sinus Surgery and endoscopically assisted transnasal pituitary gland surgery
The Endomat Select is a multi-functional, pressure-controlled, combined irrigation and suction pump. It can be used for irrigation and, where appropriate dilation, during Hysteroscopic (HYS), Arthroscopic (ART), Urological (URO) and General Surgical or Laparoscopic (SURG) interventions. The device can be used for suction during Urological (URO) and Hysteroscopic (IBS) interventions. In addition, the device can function in an oscillatory mode (ENT/Neuro) providing a fluid means to maintain lens clarity during use in Transnasal procedures. The device has a modern LCD display with touch screen user interface. The tubing sets are encoded so that they can be identified by the device, which selects the appropriate operating modes based on the tubing set connected. The device can also be connected to other Karl Storz devices using the proprietary Storz Control Bus (SCB) [K994348].
The device protects the patient from overpressure via software means. The software-controlled pressure measurement system can stop the actuator (roller pump) should the pressure rise beyond the pre-determined limit and will immediately reverse the pump roller direction to depressurize the fluid system if required. Additionally, the device has high pressure alarms to alert the operating room staff of a high-pressure situation. The device also requires positive action from the user to increase pressures above 100mmHg; the user is prompted to confirm their choice on the user interface.
The accessories for this device are provided separately. All of the accessories for use with this device are already marketed in the U.S. and are either Class I, Class II 510(k) exempt or Class II previously cleared devices. The generic tubing sets for use with this device are single use, sterile Class I accessories.
The provided text describes a 510(k) submission for the "Endomat Select" device and its substantial equivalence to predicate devices, but it does not contain the detailed acceptance criteria for a specific study, nor does it present the results of a study designed to prove the device meets such criteria.
The document primarily focuses on establishing substantial equivalence through a comparison of the Endomat Select's indications for use, technological characteristics, and non-clinical performance data against two predicate devices (KARL STORZ Endomat Select (K180735) and KARL STORZ HAMOU Endomat (K936231)).
However, I can extract information related to the performance data and "acceptance criteria" in a general sense, as implied by the "Pass" status for various verification tests.
Here's the information based on the provided document, addressing your numbered points where possible, and indicating where information is not present:
1. Table of Acceptance Criteria and Reported Device Performance
The document doesn't provide explicit numeric acceptance criteria. Instead, it lists "Verification Tests" and indicates they "Pass," implying that the device met pre-defined internal specifications.
Verification Test (Implied Acceptance Criteria) | Reported Device Performance |
---|---|
Operating Mode Activation | Pass |
Operating Mode/Software Installation | Pass |
Performance – Flow Rate | Pass |
Performance - Pressure | Pass |
Accessory Compatibility | Pass |
Safety – Error Detection | Pass |
Safety - Usability | Pass |
Overall Conclusion: | Met all design specifications |
Conclusion for Substantial Equivalence: | As safe and effective as predicate devices |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not specified. The tests are described as "bench testing," which implies laboratory or engineering testing, but the number of units or test runs is not mentioned.
- Data Provenance: Not specified, but generally, bench testing would originate from the manufacturer's R&D or testing facilities (Germany, given the applicant's address). The data is retrospective (i.e., conducted before the 510(k) submission).
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of those Experts
- Not Applicable. This type of information (experts establishing ground truth) is typically relevant for studies involving subjective human interpretation, such as image analysis for diagnostic accuracy. The reported tests are objective performance verification tests for a medical device (a pump).
4. Adjudication Method for the Test Set
- Not Applicable. Adjudication methods (like 2+1, 3+1) are used for resolving discrepancies in expert interpretations, again, relevant to subjective assessments rather than objective device performance tests.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done
- No. The document explicitly states: "Clinical testing was not required to demonstrate the substantial equivalence to the predicate devices." MRMC studies are clinical studies involving human readers.
6. If a Standalone (algorithm only without human-in-the-loop performance) was done
- Not Applicable/Not a software algorithm device. The Endomat Select is a hardware device (a pump) with software control for pressure measurement and operation modes. The performance tests are for the physical device's function, not a standalone diagnostic algorithm.
7. The Type of Ground Truth Used
- Objective Device Specifications/Design Requirements. For performance tests like flow rate and pressure, the "ground truth" would be the pre-defined target values and tolerances specified in the device's design and engineering documents. For safety and usability, it would involve adherence to relevant standards and risk analyses.
8. The Sample Size for the Training Set
- Not Applicable. This concept is relevant for machine learning algorithms. The Endomat Select is a electromechanical medical device; it does not "train" on a dataset in the way an AI algorithm does. Its software logic is programmed based on engineering principles and design specifications.
9. How the Ground Truth for the Training Set was Established
- Not Applicable. As noted above, there is no "training set" for this type of device. The functional specifications and safety parameters are established through engineering design, risk assessment, and compliance with medical device standards.
Summary of Device and Study:
The Endomat Select is a multi-functional, pressure-controlled, combined irrigation and suction pump intended for various endoscopic surgical procedures. The substantial equivalence documentation highlights its expanded hysteroscopy suction mode compared to a primary predicate, while maintaining similarity to a secondary predicate's features.
The "study" to prove the device meets acceptance criteria was a series of non-clinical bench tests. These tests verified and validated that the Endomat Select met its design specifications for operating mode activation, software installation, flow rate performance, pressure performance, accessory compatibility, error detection, and usability. The results showed that all these tests passed, leading to the conclusion that the device is as safe and effective as its predicate devices, rendering clinical testing unnecessary for this 510(k) submission.
Ask a specific question about this device
(136 days)
| 884.1690 / 884.1700
The Aveta Disposable Hysteroscope is used to permit viewing of the cervical canal and the uterine cavity for the purpose of performing diagnostic and surgical procedures.
The Aveta Disposable Hysteroscope is used by physicians in an office or operating room setting. The subject device includes the Aveta Disposable Hysteroscope and Aveta Controller. Like the Aveta Disposable Hysteroscope cleared under K190372, the modified Aveta Disposable Hysteroscope includes a camera and LED light. The Aveta Disposable Hysteroscope is connected to the Aveta Controller to provide the camera and light functions and to process and store the image obtained from the Aveta Disposable Hysteroscope.
For fluid management, the Aveta Disposable Hysteroscope can be used with gravity fed pressurized saline bag or the fluid management system cleared under K190372. For therapeutic procedures, the Aveta Disposable Hysteroscope is used with the cleared Aveta Disposable Resecting Device (K190372). The only functional buttons on the Aveta Disposable Hysteroscope handle are the image capture and the image transfer buttons. For the modified device, when other buttons on the handle are pressed, the Aveta Controller does not take any action.
Other than minor change to the Aveta Controller software to disable fluid management related buttons on the Aveta Disposable Hysteroscope, there is no change to the components of the cleared Aveta System (K190372).
This document is a 510(k) premarket notification for the "Aveta Disposable Hysteroscope" (K192100). The request is a submission to demonstrate substantial equivalence to a legally marketed predicate device (Aveta System, K190372). The provided text describes the device, its intended use, and a comparison to the predicate device. It also briefly mentions non-clinical performance testing.
However, the document does not contain information about acceptance criteria, clinical study design, sample sizes for test or training sets, expert qualifications, ground truth establishment methods, or whether MRMC or standalone performance studies were conducted.
Therefore, I cannot fulfill your request for details on the acceptance criteria and the study that proves the device meets those criteria using only the provided text for the Aveta Disposable Hysteroscope (K192100).
The provided text focuses on demonstrating substantial equivalence through non-clinical performance testing and a comparison of technological characteristics and indications for use to a predicate device. This type of submission (510(k)) typically relies on comparisons to demonstrate safety and efficacy, rather than extensive new clinical studies with detailed acceptance criteria as one might see for a PMA or novel AI/ML device where clinical performance is the primary assessment.
Based on the provided document, the only "study" mentioned is "Non-Clinical Performance Testing," which includes:
- Software verification
- Simulated Use with gravity fed pressurized saline bag: This involved demonstrating regulation of cavity pressure in a model uterine system, flow rate tests, and tissue resection.
Here's what I can extract and what is explicitly missing based on your request categories:
1. A table of acceptance criteria and the reported device performance
- Missing from the document. The document only states that "Results demonstrate the subject device met specifications" for the simulated use testing, but it does not list those specifications or acceptance criteria.
2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- Missing from the document. The non-clinical testing appears to be primarily benchtop and simulated use; therefore, there isn't a "test set" in the context of patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- Missing from the document. This is a non-clinical evaluation, so expert adjudication of patient data for ground truth is not applicable here.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Missing from the document. Not applicable for this type of non-clinical submission.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Missing from the document. This device is a hysteroscope, not an AI/ML diagnostic tool. Therefore, MRMC studies are not relevant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Missing from the document. Not applicable, as this is a medical device, not an AI algorithm. Its performance is evaluated in conjunction with human use.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
- Missing from the document. For non-clinical testing, "ground truth" would typically refer to established engineering and performance specifications validated through physical measurements and simulations, rather than clinical ground truth from patients. The document does not specify these.
8. The sample size for the training set
- Missing from the document. Not applicable, as this is not an AI/ML device requiring a training set.
9. How the ground truth for the training set was established
- Missing from the document. Not applicable.
Summary of available information related to performance:
- Device Name: Aveta Disposable Hysteroscope (K192100)
- Predicate Device: Aveta System (K190372)
- Type of Evaluation: Non-Clinical Performance Testing to demonstrate substantial equivalence to a predicate device.
- Tests Performed:
- Software verification
- Simulated Use with gravity-fed pressurized saline bag (demonstrated: regulation of cavity pressure in a model uterine system, flow rate tests, tissue resection).
- Conclusion: "The results of the non-clinical testing described above demonstrate that the subject device is as safe and effective as the predicate device and support the subject device is substantially equivalent to the predicate device."
To obtain the specific details requested in your prompt, you would need access to the full 510(k) submission (e.g., test reports) which is not typically made public in this summarized format.
Ask a specific question about this device
(70 days)
| HIH | |
| Additional Product Codes: | HIG (21 CFR 884.1700
The Aveta System is intended for intrauterine use by trained gynecologists to permit viewing of the cervical canal and the uterine cavity, provide liquid distension of the uterus and monitor the volume differential between the irrigation fluid flowing into and out of the uterus during diagnostic and surgical procedures to resect and remove tissue such as submucous myomas, endometrial polyps and retained products of conception.
The modified Aveta System is used by physicians in an office or operating room setting. The Aveta Controller acts as the hub of the system. For diagnostic procedures, the Aveta Fluid Management Accessory, the Aveta Handswitch, the Aveta Scale, the Waste Management Bags, saline bags and an external monitor are all connected to the Aveta Controller. The inflow and outflow of the fluid management accessory are connected to the corresponding ports of a compatible hysteroscope. For therapeutic procedures, the Aveta Reusable Resecting Handset or the Aveta Disposable Resecting Handset are connected to the Aveta Controller for powering the Aveta Disposable Resecting Device.
The provided text is a 510(k) summary for the Meditrina Aveta System (K191958). It describes a device that assists gynecologists in hysteroscopic procedures. This document primarily focuses on demonstrating substantial equivalence to a predicate device (K190372) rather than detailed acceptance criteria and study results for device performance in terms of diagnostic or therapeutic accuracy, as would be expected for an AI/ML powered device.
Therefore, many of the requested items (acceptance criteria for AI performance, sample size for test/training sets, expert qualifications, adjudication methods, MRMC studies, standalone AI performance, ground truth details) are not applicable or not provided in this specific 510(k) document, as it concerns a physical medical device and its accessories, not an AI/ML algorithm.
However, I can extract the available information related to the device's functional performance:
1. A table of acceptance criteria and the reported device performance:
Acceptance Criteria (Functional) | Reported Device Performance |
---|---|
Handswitch controls function as expected (Pressure and Flow Control). | Functional Testing demonstrated Handswitch controls function as expected. |
Regulation of cavity pressure demonstrated in a model uterine system. | Demonstrated with TruClear 8.0 and Myosure XL hysteroscopes in various operational modes. Results met specifications. |
2. Sample size used for the test set and the data provenance: Not applicable. The "test set" here refers to a functional performance test in a model uterine system, not a clinical data set for an AI algorithm.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable, as this was functional testing, not an expert-driven ground truth assessment.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not applicable.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This document does not describe an AI-powered device or an MRMC study.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc): For the functional testing, the "ground truth" was likely the expected physical and operational parameters (e.g., maintaining a set pressure, consistent flow control) within the model uterine system.
8. The sample size for the training set: Not applicable. No AI/ML training set is mentioned.
9. How the ground truth for the training set was established: Not applicable.
Summary of the study conducted to prove the device meets acceptance criteria:
The study conducted involved non-clinical performance testing to evaluate the modified Aveta System.
- Study Type: Functional testing and simulated use with a model uterine system.
- Key Tests:
- Functional Testing with Aveta Handswitch: Verified that the Handswitch's pressure control and flow control functions operated as expected.
- Simulated Use with Compatible Hysteroscopes: The device's ability to regulate cavity pressure was demonstrated using two commercially available hysteroscopes (Hologic MyoSure XL and Covidien TruClear 8.0) within a model uterine system. This was performed across various operational modes (diagnostic, therapeutic).
- Results: The results of these tests demonstrated that the subject device met its specifications.
- Conclusion: The non-clinical performance testing confirmed that the differences in the modified Aveta System (inclusion of Aveta Handswitch and compatibility with third-party hysteroscopes) did not raise new questions of safety and effectiveness, and the device performs as safely and effectively as its predicate.
Ask a specific question about this device
(223 days)
Re: K180735
Trade/Device Name: Endomat Select (Model Number: UP210) Regulation Number: 21 CFR§ 884.1700
|
| Regulation: | 21 CFR 884.1700
Endomat Select is intended to:
• provide the infusion of the sterile irrigant solutions into the ureter and upper urinary tract, as well as to suction off the irrigations fluids, bodily fluids, secretions, tissue and gas during diagnostic and operative endoscopic urological procedures
• provide liquid distention of the uterus for diagnostic and operative hysteroscopy
• provide the infusion of the sterile irrigant solutions into organs and operating fields during diagnostic and operative procedures in laparoscopic and open general surgery
• provide sustained liquid irrigation and distention of joint or intra-articular spaces during all phases of arthroscopic surgery
• provide the infusion of the sterile irrigant solutions in order to enable the Lens Cleaning during endoscopically assisted Functional Endoscopic Sinus Surgery and endoscopically assisted transnasal pituitary gland surgery
The Endomat Select is a multi-functional, pressure- controlled, combined irrigation and suction pump. It can be used for irrigation and, where appropriate dilation, during Hysteroscopic (HYS), Arthroscopic (ART), Urological (URO) and General Surgical or Laparoscopic (SURG) interventions. The device can be used for suction during Urological (URO) interventions. In addition the device can function in an oscillatory mode (ENT/Neuro) providing a fluid means to maintain lens clarity during use in Transnasal procedures. The device has a modern LCD display with touch screen user interface. The tubing sets are encoded so that they can be identified by the device, which selects the appropriate operating modes based on the tubing set connected. The device can also be connected to other Karl Storz devices using the proprietary Storz Control Bus (SCB) [K994348]. The device protects the patient from overpressure via software means. The software controlled pressure measurement system can stop the actuator (roller pump) should the pressure rise beyond the pre-determined limit and will immediately reverse the pump roller direction to depressurize the fluid system if required. Additionally the device has high pressure alarms to alert the operating room staff of a high pressure situation. The device also requires positive action from the user to increase pressures above 100mmHg; the user is prompted to confirm their choice on the user interface.
The Endomat Select (Model Number: UP210) is a multi-functional pressure-controlled irrigation and suction pump. The device received FDA clearance K180735 on October 31, 2018.
Acceptance Criteria and Device Performance:
The device's performance was evaluated through a series of bench tests. The detailed acceptance criteria are implied by the "Pass" status for each performance and safety test. The reported device performance is that it Passed all these tests.
Acceptance Criteria (Performance/Safety Test) | Reported Device Performance |
---|---|
Performance: Pressure Control | Pass |
Performance: Flow Limitation | Pass |
Performance: Flow Control | Pass |
Performance: Pressure Limitation | Pass |
Performance: Suction Control | Pass |
Safety: Overpressure Warning (in pressure relevant GYN and URO interventions) | Pass |
Safety: Overpressure Warning (in pressure relevant ARTHRO interventions) | Pass |
Safety: Overpressure Alarm (in pressure relevant GYN and URO interventions) | Pass |
Safety: Pressure Relief (in pressure relevant GYN and URO interventions) | Pass |
Study Details:
-
Sample size used for the test set and data provenance:
The document states that "Additional bench testing was performed to ensure the device met its design specifications." and "The bench testing performed verified and validated that the Endomat Select has met all its design specification and is substantially equivalent to its predicate devices." However, specific sample sizes for these bench tests are not provided in this document. The data provenance is also not explicitly stated beyond being "bench testing." It is implied to be from the manufacturer, Karl Storz SE & Co. KG, located in Germany. -
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not provided as the evaluation was based on non-clinical bench testing against design specifications and established standards, rather than expert-derived ground truth from a test set involving human interpretation. -
Adjudication method for the test set:
This information is not applicable as the evaluation was based on objective bench tests against pre-defined engineering and safety standards, rather than subjective interpretation requiring adjudication. -
If a multi reader multi case (MRMC) comparative effectiveness study was done, and the effect size:
No, a multi-reader multi-case (MRMC) comparative effectiveness study was not performed. The document explicitly states: "Clinical testing was not required to demonstrate the substantial equivalence to the predicate devices. Non-clinical bench testing was sufficient to assess safety and effectiveness and to establish the substantial equivalence." Therefore, no effect size of human readers improving with AI vs. without AI assistance is reported. -
If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
This device is a medical pump, not an algorithm or AI-powered system designed for diagnostic aid or similar tasks that would have standalone algorithm-only performance. Its performance is inherent in its mechanical and software functions. The "Performance" and "Safety" tests listed above can be considered standalone performance evaluations of the device's functional capabilities. -
The type of ground truth used:
The ground truth for the verification of the Endomat Select was based on design specifications and compliance with FDA recognized consensus standards and FDA Guidances. These include:- Electrical Safety and EMC (IEC 60601-1, IEC 60601-1-2, IEC 60601-1-8)
- Software Verification and Validation Testing (Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices, May 11, 2005)
- Summative Usability Testing (IEC 62366)
- Performance Testing for Hysteroscopic and Laparoscopic Insufflators (Submission Guidance For A 510(K), August 1, 1995 for Product Code HIG)
- Additional bench testing against design specifications.
-
The sample size for the training set:
This information is not applicable as the device is not an AI/ML product developed using a training set in the conventional sense. Its development involved engineering design, software development, and testing against specifications. -
How the ground truth for the training set was established:
This information is not applicable for the same reason as above.
Ask a specific question about this device
(126 days)
01752
Re: K180825
Trade/Device Name: Fluent Fluid Management System Regulation Number: 21 CFR& 884.1700
Fluid Management System Common/Usual Name: Hysteroscopic Insufflator Regulation Number: 21.CFR.Reg 884.1700
The Fluent Fluid Management System is intended to provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus while providing drive, control and suction for hysteroscopic morcellators.
The Fluent Fluid Management System is a hysteroscopic fluid management system and drive console for hysteroscopic morcellators. The Fluent Fluid Management System consists of a console and single-use procedure kit. The single use procedure kit consists of a sterile Inflow Tube Set (In-FloPak) and Outflow Tube Set (Out-FloPak) with a nonsterile Waste Bag. The two FloPaks and Waste Bag connect to the Console for performing hysteroscopic procedures. The console includes motors that control inflow and outflow of fluid for hysteroscopic insufflation, as well as a pressure sensor monitoring system and graphical user interface touchscreen. In addition, the console includes a connection for MyoSure Tissue Removal Devices and a pneumatic foot pedal to perform tissue removal procedures. The Fluent Fluid Management System is compatible with currently marketed MyoSure Tissue Removal Devices. The primary functions of the subject device are fluid distension, fluid deficit tracking, and morcellator drive control. The subject device includes a deficit alert feature as well as an overpressure protection mechanism.
Here's an analysis of the provided text to extract information about acceptance criteria and the study that proves the device meets them:
Disclaimer: The provided text is a 510(k) summary, which focuses on demonstrating substantial equivalence to predicate devices rather than providing a comprehensive clinical study report with detailed acceptance criteria and performance data in a structured format. Therefore, I will extract relevant information where available, and note when specific details (like numerical acceptance criteria or clinical study specifics) are not explicitly stated.
Acceptance Criteria and Device Performance
The 510(k) summary does not explicitly present a table of acceptance criteria with corresponding reported device performance values in a quantifiable manner that is typical for a clinical study. Instead, it relies on demonstrating that the new device's performance is "substantially equivalent" to the predicate devices. The performance testing section describes categories of tests conducted, implying that the device successfully met internal specifications and standards relevant to those tests.
However, based on the "Comparison of Technological Characteristics" Table 5-1 and the "Performance Testing" section, we can infer some operational parameters and functional aspects that would have associated acceptance criteria internally.
Performance Characteristic (Inferred Acceptance Criteria) | Reported Device Performance (Fluent Fluid Management System) | Notes / Implicit Acceptance |
---|---|---|
Fluid Management System | ||
Pressure Control Range | 40-120 mmHg | Different from Predicate 1 (40-150 mmHg), but within safe and effective range. No specific acceptance threshold for this range is given. |
Maximum Intrauterine Pressure | 120 mmHg | Different from Predicate 1 (150 mmHg), but within safe limits. |
Flow rate (maximum) | 650 mL/min | Different from Predicate 1 (800 mL/min), but deemed acceptable for use. |
Overpressure Protection | Yes | Same as Predicate 1. Implied: Must function reliably. |
Fluid Deficit Tracking | Yes | Same as Predicate 1. Implied: Must accurately track fluid deficit. |
Drive Control Console for Hysteroscopic Morcellators | ||
Morcellator Drive Rotation Speed | 8075 ± 1000 RPM | Same as Predicate 2. Implied: Must maintain this speed within tolerance. |
Sterility and Shelf Life | ||
EtO Sterilization | Per ISO 11135:2014 & ISO 10993-7:2008 | Successful completion implies acceptance. |
Package Integrity | Per ASTM F1980-16 | Successful completion implies acceptance. |
Shelf Life (Sterile Components) | Three-year shelf life confirmed | Confirmed by accelerated aging and functional testing. |
Biocompatibility | ||
Cytotoxicity | ISO 10993-5:2009 compliant | Successful completion implies acceptance. |
Sensitization | ISO 10993-10:2010 compliant | Successful completion implies acceptance. |
Irritation | ISO 10993-10:2010 compliant | Successful completion implies acceptance. |
Acute System Toxicity | ISO 10993-11:2006 compliant | Successful completion implies acceptance. |
Software | ||
System Design Control Verification & Validation | Successfully performed, Major Level of Concern | In accordance with FDA Guidance (May 2005). Successful completion implies acceptance. |
Electrical Safety and EMC | ||
Medical Electrical Equipment Standards | IEC 60601-1:2005, IEC 60601-1-2:2007, IEC 60601-1-6:2010 | Successful completion implies acceptance. |
Performance Testing (Functional) | ||
Inflow/Outflow Tubing Sets | Design verification (mechanical testing) | Successful completion implies acceptance. |
Inflow Rate, Outflow Rate, TRD Suction | Fluid management validation testing to assess | Successful completion implies acceptance. |
Intrauterine Pressure Control | Testing conducted | Successful completion implies acceptance. |
System cutting performance | For the drive control system | Successful completion implies acceptance. |
Study Details:
-
Sample size used for the test set and the data provenance:
- The document describes non-clinical performance testing (design verification, fluid management validation, intrauterine pressure control, system performance, system cutting performance).
- It does not specify sample sizes for these tests (e.g., how many units were tested, how many trials were conducted for each metric).
- The data provenance is internal to Hologic, Inc. (the manufacturer), as these are manufacturing and engineering validation tests. There's no mention of external data or specific countries of origin beyond the company's location in Marlborough, MA, USA.
- These tests are inherently prospective in nature, as they involve testing the manufactured device against pre-defined specifications.
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience):
- This question is not applicable in the context of the provided 510(k) summary. The summary describes engineering and performance validation tests for a medical device (hysteroscopic insufflator/morcellator drive), not a diagnostic algorithm or a clinical study requiring expert assessment of medical images or patient outcomes to establish ground truth. The "ground truth" for these tests would be the established engineering specifications and regulatory standards.
-
Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- This question is not applicable as the tests described are technical performance validations, not clinical assessments requiring adjudication by multiple experts. The results of the engineering tests would be pass/fail against predetermined specifications.
-
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No, an MRMC comparative effectiveness study was not done. This type of study is relevant for diagnostic imaging AI devices, where the AI assists human readers (e.g., radiologists). The Fluent Fluid Management System is a surgical assist device, not a diagnostic imaging device with an AI component for human reader assistance.
-
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- This device is a hardware system with integrated software for fluid management and morcellator control. Its "performance" is inherently standalone in the sense that the system itself performs its functions (e.g., maintaining pressure, tracking deficit, driving the morcellator) without direct human-in-the-loop influence on those specific operations. However, the device is used by a human surgeon. There is no "algorithm only" performance study in the typical AI sense. The performance tests (fluid management, cutting performance) were done on the device itself.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- For the non-clinical performance testing, the "ground truth" refers to the engineering specifications, design requirements, and applicable industry standards (e.g., ISO, ASTM, IEC standards for sterilization, biocompatibility, electrical safety, and performance metrics as defined by the manufacturer). There is no "expert consensus," "pathology," or "outcomes data" ground truth discussed for these particular non-clinical studies.
-
The sample size for the training set:
- This question is not applicable as this is not an AI/machine learning device that requires a "training set" in the conventional sense. The device's software is built on established algorithms for control, not on learning from a large dataset.
-
How the ground truth for the training set was established:
- This question is not applicable for the same reasons as point 7.
Ask a specific question about this device
(135 days)
8 Berlin, 10587 Germanv
Re: K173489
Trade/Device Name: GYN-Pump PH304 Regulation Number: 21 CFR§ 884.1700
|
| Regulation Number: | 21 C.F.R. § 884.1700
|
| Classification Name: | Hysteroscopic Insufflator |
| Regulation Number: | 21 C.F.R. § 884.1700
The GYN-Pump PH304 is a combined suction and irrigation pump for use in hysteroscopic and laparoscopic interventions. During diagnostic and operative hysteroscopy, the GYN-Pump PH304 is intended to provide liquid distension of the uterus and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus. During diagnostic and therapeutic laparoscopic procedures, the GYN-Pump PH304 is intended to irrigate fluid into and remove fluid from the abdominal cavity.
The GYN-Pump PH304 is a microprocessor controlled single roller pump that functions according to the peristaltic principle. It transports sterile irrigation fluid to distend the uterus and provides fluid deficit monitoring during operative hysteroscopy. It is also used to irrigate the abdominal cavity during laparoscopy and provides fluid aspiration. The pump consists of the following main components: a power supply, a power switch, a touch display, a connection for the suction function, a roller wheel, a pump head and a casing. The proposed pump is designed to be used with the Fluid Monitoring Unit PS304 in order to assist with fluid deficit monitoring. The Fluid Monitoring Unit PS304 is a component of the GYN-Pump PH304 and together they are a medical electrical system. The pump must be used with the following tube sets: Standard Irrigation Tube Set (also referred to as "ST261"), Suction Tube Set (one connection, "I"-shape; also referred to as "ST287"), Suction Tube Set (two connections, "Y"-shape; also referred to as "ST282"), Vacuum Tube Set (also referred to as "ST291").
The medical device in question is the GYN-Pump PH304, a combined suction and irrigation pump for hysteroscopic and laparoscopic interventions.
Here's an analysis of the acceptance criteria and the study that proves the device meets them, based on the provided text:
1. Table of Acceptance Criteria and Reported Device Performance:
The document focuses on comparing the GYN-Pump PH304 to its predicate devices, rather than explicitly stating acceptance criteria in a standalone table within the performance section. However, the comparative table on page 7 and the subsequent discussion implicitly define the performance targets for the GYN-Pump PH304 by referencing the predicate devices' specifications and emphasizing improvements or equivalency.
Feature / Performance Metric | Acceptance Criteria (Implicit, based on Predicate Devices or Improvement) | GYN-Pump PH304 Reported Performance |
---|---|---|
Hysteroscopy | ||
Deficit Accuracy | +/- 10 % (primary predicate: Aquilex) or better | +/- 6 % (improved from predicate) |
Pressure Setting Range | 40 - 150 mmHg (primary predicate: Aquilex) | 15 - 150 mmHg |
Max. Pressure Setting | Max. 150 mmHg (primary predicate: Aquilex) | Max. 150 mmHg |
Max. Flow Rate | 800 mL/min (primary predicate: Aquilex) | 800 mL/min |
Flow Setting Range | ≤ 800 mL/min (not user adjustable for Aquilex) | 50-800 mL/min |
Positive Action to Increase Above 100 mmHg | Yes (primary predicate: Aquilex) | Yes |
Overpressure Warnings | Yes (primary predicate: Aquilex) | Yes |
Deficit Limit Warning | Yes (primary predicate: Aquilex) | Yes |
High Deficit Rate Warning | Yes (primary predicate: Aquilex) | Yes |
Laparoscopy | ||
Max. Pressure | 450 mmHg (secondary predicate: LAP-Pump) | 500 mmHg (not adjustable) |
Max. Flow Rate (Standard Tube Set) | 2.0 l/min (secondary predicate: LAP-Pump) | 2.0 l/min |
Suction Pressure (High level) | 300 to 500 mmHg (primary predicate: Aquilex), 450 mmHg (secondary predicate: LAP-Pump) | 450 mmHg (for GYN-Pump PH304) |
Suction Pressure (Low level) | 225 mmHg (primary predicate: Aquilex) | 225 mmHg |
General Device Specifications | ||
Pump type | Peristaltic, roller (same as predicates) | Peristaltic, roller |
Tube Set Recognition (RFID) | Yes (same as predicates) | Yes |
Automatic Instrument Detection | Yes (same as primary predicate) | Yes |
Medium to be Used | Isotonic or hypotonic solutions (same as predicates) | Isotonic or hypotonic solutions |
2. Sample Sizes Used for the Test Set and Data Provenance:
The document describes bench tests for performance.
- Comparative Bench Test – Fluid Deficit Measurement: This test compared the GYN-Pump PH304 to the Aquilex Fluid Control System H112. The sample size for fluid deficit measurement is not explicitly stated in terms of number of procedures or specific data points. It mentions "fluid was dispensed through the system," implying a controlled experimental setup.
- Pressure Regulation Bench Test: This test involved connecting the GYN-Pump PH304 to a model system and cycling it through a range of flow rates and pressures. The sample size is not explicitly stated.
- Data Provenance: The studies were bench tests, conducted in a controlled laboratory environment by the manufacturer (W.O.M. World of Medicine GmbH). The country of origin for the studies would be Germany, where the manufacturer is located. The studies are prospective in nature, as they were conducted to evaluate the performance of the newly developed GYN-Pump PH304.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
The document does not mention the involvement of experts (e.g., clinicians, radiologists) to establish ground truth for the bench tests. Ground truth for these performance tests was established through manual measurement (for fluid deficit) and continuous monitoring and recording (for pressure regulation) within the experimental setup, likely using calibrated instruments. The expertise would lie in the engineers and technicians conducting the validation tests according to established protocols and standards.
4. Adjudication Method for the Test Set:
No adjudication method (like 2+1 or 3+1) is mentioned as these were bench tests of a physical device's performance against predefined quantifiable metrics, not assessments of qualitative outputs or interpretations that would require expert consensus.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:
No MRMC comparative effectiveness study was done. The studies described are bench tests comparing device performance to predicate devices and predefined specifications, not human reader performance with or without AI assistance. Therefore, no effect size of human readers improving with AI vs without AI assistance is reported.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done:
The device (GYN-Pump PH304) is a physical pump with embedded software, not an AI algorithm for diagnostic interpretation. The performance data presented is for the standalone device operating according to its design specifications in a test environment. Thus, a "standalone" performance study in the context of an AI algorithm is not applicable here, but the described bench tests effectively serve as standalone performance evaluations of the device.
7. The Type of Ground Truth Used:
- Bench Tests (Fluid Deficit Measurement): Ground truth was established through manual measurement of the fluid deficit. This involved a direct and objective physical measurement to compare against the device's computed deficit.
- Bench Tests (Pressure Regulation): Ground truth was established through continuously monitored and recorded pressure data from the model system, likely using highly accurate pressure transducers or sensors.
8. The Sample Size for the Training Set:
The GYN-Pump PH304 is a hardware device with embedded software logic, not an AI/machine learning system that requires a "training set" of data in the conventional sense. The software development, testing, and verification followed standards like IEC 62304, which involves rigorous development and testing phases, but not a "training set" of patient data as understood in AI/ML.
9. How the Ground Truth for the Training Set was Established:
As there is no "training set" in the context of an AI/ML algorithm for this device, this question is not applicable. The software's "ground truth" or correct functioning is established through comprehensive software verification and validation activities (unit testing, integration testing, system testing) against its design specifications and requirements, as per IEC 62304.
Ask a specific question about this device
(215 days)
GERMANY
K172040 Re:
Trade/Device Name: Aquilex® Fluid Control System AOL-100S Regulation Number: 21 CFR 884.1700
|
| Regulation Number: | 21 CFR 884.1700
|
| Regulation Number: | 21 CFR 884.1700
WORLD OF MEDICINE GmbH |
| Regulation Number: | 21 CFR 884.1700 |
| Regulatory Class:
The Aquilex® Fluid Control System AQL-100S is intended to provide fluid distension of the uterus during diagnostic and operative hysteroscopy and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus.
The Aquilex® Fluid Control System AQL-100S is a modified version of the primary predicate device, Aquilex Fluid Control System H112 (K112642). The proposed device is a microprocessor-controlled device that consists of the following two main components: (1) an irrigation pump unit including suction pumps (AQL-110P) and (2) and fluid monitoring unit (AQL-100CBS) that are to be placed on a roller stand. The irrigation pump unit (AQL-110P) of the Aquilex® Fluid Control System AQL-100S is a microprocessor-controlled device that functions according to the peristaltic principle and consists of the following components: (1) a casing. (2) a power switch, (3) a power supply, (4) mains cable, (5) a roller wheel, (6) a pump head, (7) suction pumps, (8) various setting keys and (9) display elements. The irrigation pump unit (AQL-110P) is to be used with specially designed single use irrigation and outflow tube sets that are delivered sterile (AQL-110 and AQL-111). In addition, the suction pumps of the irrigation pump unit are to be used with specially designed non-sterile vacuum tube sets (AQL-114). The fluid monitoring unit (AQL-100CBS) consists of the following main components: (1) two scale units, (2), a bag holder, (4) a bag deflector, (5) a container holder, and (6) a roller wheel base. The irrigation pump unit of the proposed device is only operational in conjunction with the fluid monitoring unit.
The provided document in the prompt relates to a 510(k) premarket notification for a medical device called the "Aquilex® Fluid Control System AQL-100S." This document describes the device, its intended use, comparison to predicate devices, and a summary of performance data collected to demonstrate substantial equivalence.
However, the document does not contain specific acceptance criteria tables nor detailed results from a clinical study proving the device meets those criteria. Instead, it provides a summary of various bench tests and compliance with standards (electrical safety, EMC, software, biocompatibility, sterilization, shelf life) to support its substantial equivalence claim, rather than a clinical study with acceptance criteria for device performance in a real-world or simulated clinical setting.
Therefore, many of the requested details about acceptance criteria, study design, sample sizes, expert involvement, and ground truth cannot be extracted directly from this document in the manner typically associated with studies demonstrating performance against specific clinical or diagnostic metrics.
Based on the available information, here's what can be inferred and what cannot:
1. A table of acceptance criteria and the reported device performance:
The document mentions "Bench testing was performed to demonstrate that the fluid deficit determination...is substantially equivalent...in terms of accuracy." However, it does not provide a specific table of acceptance criteria for this accuracy or the reported numerical performance values (e.g., mean accuracy, standard deviation, or specific thresholds).
2. Sample size used for the test set and the data provenance:
- Test Set Sample Size: Not specified for any of the performance tests. The bench testing refers to "fluid deficit determination" but doesn't quantify the number of measurements or conditions.
- Data Provenance: The tests (electrical safety, EMC, software verification/validation, biocompatibility, sterilization, shelf life, bench testing) are described as performed by "independent laboratories" or internally. No information on country of origin of data or whether it was retrospective or prospective is given, as these are typically laboratory/bench tests, not clinical studies.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience):
Not applicable. The performance tests described are laboratory-based and do not involve human interpretation or subjective assessment that would require "experts to establish ground truth" in the clinical sense.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:
Not applicable. There's no human adjudication involved in the described bench and standard compliance tests.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
Not applicable. This device is a fluid control system, not an AI or imaging diagnostic device that would involve human readers or MRMC studies.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:
The performance tests are essentially standalone for the device, as they assess its functional capabilities (e.g., electrical safety, fluid deficit accuracy) without human intervention in the primary measurement. However, this is not an "algorithm only" study in the context of AI, but rather a functional characterization of hardware and software.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
For the bench testing related to "fluid deficit determination," the ground truth would likely be established by highly accurate reference measurement systems (e.g., precise scales or flow meters) that are calibrated and traceable to known standards. This is inherent in laboratory bench testing. The document doesn't explicitly state the specifics of this ground truth.
8. The sample size for the training set:
Not applicable. This is not an AI-driven device requiring a training set in the typical machine learning sense. The software development and testing, while mentioned (IEC 62304), refers to traditional software verification and validation, not machine learning model training.
9. How the ground truth for the training set was established:
Not applicable, as there is no training set for an AI model.
Summary of available information:
Criterion | Details from Document |
---|---|
Acceptance Criteria & Reported Performance | Acceptance Criteria: Unspecified. The document states bench testing was performed to demonstrate "fluid deficit determination...is substantially equivalent...in terms of accuracy" to the predicate device (Hysteroscopy Pump HM6). No numerical acceptance thresholds or target accuracy values are provided. |
Reported Performance: No specific numerical performance values (e.g., accuracy percentages, error ranges) are reported for the fluid deficit determination. The conclusion is that the device "is substantially equivalent" to the predicate for this function. |
| Test Set Sample Size | Not specified for any of the performance tests. |
| Data Provenance | Tests performed by "independent laboratories" or internally. No details on country of origin or retrospective/prospective nature. |
| Number & Qualifications of Experts for Ground Truth | Not applicable; tests are laboratory-based, not reliant on expert clinical interpretation for ground truth. |
| Adjudication Method for Test Set | Not applicable; no human adjudication involved in these functional tests. |
| MRMC Comparative Effectiveness Study | No. This is a fluid control system, not an imaging/AI diagnostic device. |
| Standalone Performance Study | Yes, the various bench, electrical safety, EMC, software, biocompatibility, sterilization, and shelf-life tests assess the device's performance in a standalone context against relevant standards and predicate device functions. |
| Type of Ground Truth Used | For "fluid deficit determination," ground truth would be established by precise, calibrated reference measurement systems in a laboratory setting. Not explicitly detailed in the document. |
| Training Set Sample Size | Not applicable; this device does not use machine learning that requires a training set. Software verification and validation followed IEC 62304. |
| How Training Set Ground Truth was Established | Not applicable; no training set for AI. |
The document primarily relies on demonstrating compliance with recognized standards (IEC 60601-1, IEC 60601-1-2, IEC 62304, ISO 10993 series, ISO 11135, ISO 14937, ISO 11607-1, ASTM-F1980) and bench testing indicating functional equivalence to a predicate device for its 510(k) clearance, rather than reporting detailed clinical study results with explicit acceptance criteria often found for diagnostic or treatment efficacy devices.
Ask a specific question about this device
Page 1 of 3